SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cor Therapeutics Inc. (CORR) -- Ignore unavailable to you. Want to Upgrade?

To: wolfdog2 who wrote (327)1/14/1999 9:44:00 PM
From: aknahow  Read Replies (1) | Respond to of 712
 
Thanks, I also appreciated Mayos post. Guess it's a matter of perspective. I still have trouble see the article as damning the ramp up. But that is o.k. In many years of investing and having had access to various publications, including the real Bloomberg, Grants Interest Rate Observer and The Bank Credit Analyst, I end up finding thestreet.com to be a whole new investment tool. I like it so much, I am probably blind to its' defects.

I am being sincere when I say post here have helped more than I would usually care to admit. I believe the insights into what one cath lab has done are important. I trust the person that made that particular post. That one post was worth more to me than being at the H & Q Conference, which I wasn't. <g>



To: wolfdog2 who wrote (327)1/15/1999 5:31:00 PM
From: Henry Niman  Respond to of 712
 
Michael Murphy was just on CNBC to talk about Biotechs. He indicated that the sector had over 200 products (in late stage? trials) and said that products were finally coming to market. He suggested investors target companies with products just coming to market and mentioned CEPH, CORR, LGND, and ISIP.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News